Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing
A. David Paltiel and
Harold A. Pollack
Additional contact information
A. David Paltiel: School of Medicine/School of Management, Yale University, New Haven, Connecticut, david.paltiel@yale.edu
Harold A. Pollack: School of Social Service Administration/Center for Health Administration Studies, University of Chicago, Chicago, Illinois
Medical Decision Making, 2010, vol. 30, issue 2, 217-223
Abstract:
The Food and Drug Administration (FDA) is considering approval of an over-the-counter, rapid HIV test for home use. To support its decision, the FDA seeks evidence of the test’s performance. It has asked the manufacturer to conduct field studies of the test’s sensitivity and specificity when employed by untrained users. In this article, the authors argue that additional information should be sought to evaluate the prevalence of undetected HIV in the end-user population. The analytic framework produces the elementary but counterintuitive finding that the performance of the home HIV test— measured in terms of its ability to correctly detect the presence and absence of HIV infection among the people who purchase it—depends critically on the manufacturer’s retail price. This finding has profound implications for the FDA’s approval process.
Keywords: HIV testing; FDA; predictive value. (search for similar items in EconPapers)
Date: 2010
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X09334420 (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:30:y:2010:i:2:p:217-223
DOI: 10.1177/0272989X09334420
Access Statistics for this article
More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().